About
Biomoneta develops and markets FDA-cleared air decontamination hardware that eliminates over 99.999% of airborne pathogens including multidrug-resistant bacteria, viruses, and fungi to prevent infections in healthcare, pharmaceutical, and biotechnology environments.
Explore Biomoneta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.